428 related articles for article (PubMed ID: 18773991)
1. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
[TBL] [Abstract][Full Text] [Related]
2. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome.
Arsenault BJ; Lachance D; Lemieux I; Alméras N; Tremblay A; Bouchard C; Pérusse L; Després JP
Arch Intern Med; 2007 Jul; 167(14):1518-25. PubMed ID: 17646606
[TBL] [Abstract][Full Text] [Related]
3. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
4. Aortic augmentation index is inversely associated with cardiorespiratory fitness in men without known coronary heart disease.
Binder J; Bailey KR; Seward JB; Squires RW; Kunihiro T; Hensrud DD; Kullo IJ
Am J Hypertens; 2006 Oct; 19(10):1019-24. PubMed ID: 17027821
[TBL] [Abstract][Full Text] [Related]
5. Correlation of exercise capacity with high-sensitive C-reactive protein in patients with stable coronary artery disease.
Rahimi K; Secknus MA; Adam M; Hayerizadeh BF; Fiedler M; Thiery J; Schuler G
Am Heart J; 2005 Dec; 150(6):1282-9. PubMed ID: 16338272
[TBL] [Abstract][Full Text] [Related]
6. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
Kadoglou NP; Iliadis F; Angelopoulou N; Sailer N; Fotiadis G; Voliotis K; Vitta I; Liapis CD; Alevizos M
J Diabetes Complications; 2009; 23(3):160-6. PubMed ID: 18413173
[TBL] [Abstract][Full Text] [Related]
7. Physical activity, cardiorespiratory fitness and the incidence of type 2 diabetes in a prospective study of men.
Sieverdes JC; Sui X; Lee DC; Church TS; McClain A; Hand GA; Blair SN
Br J Sports Med; 2010 Mar; 44(4):238-44. PubMed ID: 19656767
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cardiorespiratory fitness and lipoprotein(a) in men and women.
Israel RG; Sullivan MJ; Marks RH; Cayton RS; Chenier TC
Med Sci Sports Exerc; 1994 Apr; 26(4):425-31. PubMed ID: 8201897
[TBL] [Abstract][Full Text] [Related]
9. Competing impact of excess weight versus cardiorespiratory fitness on cardiovascular risk.
Diaz VA; Player MS; Mainous AG; Carek PJ; Geesey ME
Am J Cardiol; 2006 Dec; 98(11):1468-71. PubMed ID: 17126652
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
11. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
[TBL] [Abstract][Full Text] [Related]
13. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
14. Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
Väisänen S; Baumstark MW; Penttilä I; Bouchard C; Halonen P; Rankinen T; Berg A; Rauramaa R
Thromb Haemost; 1997 Dec; 78(6):1495-9. PubMed ID: 9423801
[TBL] [Abstract][Full Text] [Related]
15. Markers of inflammation are inversely associated with VO2 max in asymptomatic men.
Kullo IJ; Khaleghi M; Hensrud DD
J Appl Physiol (1985); 2007 Apr; 102(4):1374-9. PubMed ID: 17170204
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
[TBL] [Abstract][Full Text] [Related]
17. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
[TBL] [Abstract][Full Text] [Related]
19. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
[TBL] [Abstract][Full Text] [Related]
20. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
Hammett CJ; Prapavessis H; Baldi JC; Varo N; Schoenbeck U; Ameratunga R; French JK; White HD; Stewart RA
Am Heart J; 2006 Feb; 151(2):367.e7-367.e16. PubMed ID: 16442901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
